Gilead Sciences buys US firm Kite Pharma for $11.9bn

Biopharmaceutical company Gilead Sciences has completed the acquisition of US-based Kite Pharma for approximately $11.9bn.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news